BACKGROUND AND PURPOSE: While the slow delayed rectifier K(+) current (I(Ks)) is known to be enhanced by the stimulation of β-adrenoceptors in several mammalian species, phosphorylation-dependent regulation of the rapid delayed rectifier K(+) current (I(Kr)) is controversial. EXPERIMENTAL APPROACH: In the present study, therefore, the effect of isoprenaline (ISO), activators and inhibitors of the protein kinase A (PKA) pathway on I(Kr) and I(Ks) was studied in canine ventricular myocytes using the whole cell patch clamp technique. KEY RESULTS: I (Kr) was significantly increased (by 30-50%) following superfusion with ISO, forskolin or intracellular application of PKA activator cAMP analogues (cAMP, 8-Br-cAMP, 6-Bnz-cAMP). Inhibition of PKA by Rp-8-Br-cAMP had no effect on baseline I(Kr). The stimulating effect of ISO on I(Kr) was completely inhibited by selective β₁-adrenoceptor antagonists (metoprolol and CGP-20712A), by the PKA inhibitor Rp-8-Br-cAMP and by the PKA activator cAMP analogues, but not by the EPAC activator 8-pCPT-2'-O-Me-cAMP. In comparison, I(Ks) was increased threefold by the activation of PKA (by ISO or 8-Br-cAMP), and strongly reduced by the PKA inhibitor Rp-8-Br-cAMP. The ISO-induced enhancement of I(Ks) was decreased by Rp-8-Br-cAMP and completely inhibited by 8-Br-cAMP. CONCLUSIONS AND IMPLICATIONS: The results indicate that the stimulation of β₁-adrenoceptors increases I(Kr), similar to I(Ks), via the activation of PKA in canine ventricular cells.
BACKGROUND AND PURPOSE: While the slow delayed rectifier K(+) current (I(Ks)) is known to be enhanced by the stimulation of β-adrenoceptors in several mammalian species, phosphorylation-dependent regulation of the rapid delayed rectifier K(+) current (I(Kr)) is controversial. EXPERIMENTAL APPROACH: In the present study, therefore, the effect of isoprenaline (ISO), activators and inhibitors of the protein kinase A (PKA) pathway on I(Kr) and I(Ks) was studied in canine ventricular myocytes using the whole cell patch clamp technique. KEY RESULTS: I (Kr) was significantly increased (by 30-50%) following superfusion with ISO, forskolin or intracellular application of PKA activator cAMP analogues (cAMP, 8-Br-cAMP, 6-Bnz-cAMP). Inhibition of PKA by Rp-8-Br-cAMP had no effect on baseline I(Kr). The stimulating effect of ISO on I(Kr) was completely inhibited by selective β₁-adrenoceptor antagonists (metoprolol and CGP-20712A), by the PKA inhibitor Rp-8-Br-cAMP and by the PKA activator cAMP analogues, but not by the EPAC activator 8-pCPT-2'-O-Me-cAMP. In comparison, I(Ks) was increased threefold by the activation of PKA (by ISO or 8-Br-cAMP), and strongly reduced by the PKA inhibitor Rp-8-Br-cAMP. The ISO-induced enhancement of I(Ks) was decreased by Rp-8-Br-cAMP and completely inhibited by 8-Br-cAMP. CONCLUSIONS AND IMPLICATIONS: The results indicate that the stimulation of β₁-adrenoceptors increases I(Kr), similar to I(Ks), via the activation of PKA in canine ventricular cells.
Authors: Christoph A Karle; Edgar Zitron; Wei Zhang; Sven Kathöfer; Wolfgang Schoels; Johann Kiehn Journal: Cardiovasc Res Date: 2002-02-01 Impact factor: 10.787
Authors: Zhang Wei; Dierk Thomas; Christoph A Karle; Sven Kathöfer; Johannes Schenkel; Volker A W Kreye; Eckhard Ficker; Barbara A Wible; Johann Kiehn Journal: Chin Med J (Engl) Date: 2002-05 Impact factor: 2.628
Authors: Dierk Thomas; Wei Zhang; Kezhong Wu; Anna-Britt Wimmer; Bernd Gut; Gunnar Wendt-Nordahl; Sven Kathöfer; Volker A W Kreye; Hugo A Katus; Wolfgang Schoels; Johann Kiehn; Christoph A Karle Journal: Cardiovasc Res Date: 2003-07-01 Impact factor: 10.787
Authors: Gergely Szabó; Norbert Szentandrássy; Tamás Bíró; Balázs I Tóth; Gabriella Czifra; János Magyar; Tamás Bányász; András Varró; László Kovács; Péter P Nánási Journal: Pflugers Arch Date: 2005-06-11 Impact factor: 3.657
Authors: J Magyar; T Bányász; P Szigligeti; A Körtvély; A Jednákovits; P P Nánási Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2000-03 Impact factor: 3.000
Authors: Jorge A Negroni; Stefano Morotti; Elena C Lascano; Aldrin V Gomes; Eleonora Grandi; José L Puglisi; Donald M Bers Journal: J Mol Cell Cardiol Date: 2015-02-25 Impact factor: 5.000
Authors: Ferenc Ruzsnavszky; Bence Hegyi; Kornél Kistamás; Krisztina Váczi; Balázs Horváth; Norbert Szentandrássy; Tamás Bányász; Péter P Nánási; János Magyar Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 2014-02-25 Impact factor: 3.000
Authors: Nipavan Chiamvimonvat; Ye Chen-Izu; Colleen E Clancy; Isabelle Deschenes; Dobromir Dobrev; Jordi Heijman; Leighton Izu; Zhilin Qu; Crystal M Ripplinger; Jamie I Vandenberg; James N Weiss; Gideon Koren; Tamas Banyasz; Eleonora Grandi; Michael C Sanguinetti; Donald M Bers; Jeanne M Nerbonne Journal: J Physiol Date: 2017-01-05 Impact factor: 5.182
Authors: N Szentandrássy; V Farkas; L Bárándi; B Hegyi; F Ruzsnavszky; B Horváth; T Bányász; J Magyar; I Márton; P P Nánási Journal: Br J Pharmacol Date: 2012-10 Impact factor: 8.739